Ministry of Public Health, Department of Medical Sciences Piloting the public to access pharmacogenetic test results. Create a digital platform system “Tie-Breed” for doctors to use data to plan prevention and treatment of specific diseases. and more accurate Prevent severe drug allergies

Dr. Yongyot Thamwut, Deputy Permanent Secretary of the Ministry of Public Health Acting Director-General of the Department of Medical Sciences said that the Department of Medical Sciences sees the importance of patients' severe drug allergies. Therefore, we created a digital platform system “Bybreed” to report the results of genetic testing of patients. To assess the chance of a severe drug allergy in the patient, how likely is it? The pharmacogenetic test will allow the treating doctor to choose medicine or adjust the dosage that is appropriate for the patient and will keep the patient safe from drug allergies. The results of a single pharmacogenetic test can be used for life. Doctors, pharmacists, and patients can access the laboratory test results of the Department of Medical Sciences and use them for further treatment. This is the first genetic test. The Department of Medical Sciences is piloting services for the public, including pharmacogenetic test results and to prevent severe drug allergies. It is divided into 4 tests: 1. HLA-B 58:01 gene test for the group of patients receiving allopurinol. (Allopurinol) 2. HLA-B gene test 15:02 for the group of patients receiving carbamazepine. (Carbamazepine) 3. HLA-B*57:01 gene testing for patients receiving Abacavir and 4. NAT2 gene subgene testing in tuberculosis patients receiving cough medicine. Isoniazid, which currently includes 4 pharmacogenetic tests, can be tested at 14 network laboratories of the Department of Medical Sciences throughout the country, with a pilot "coding" at Maharat Hospital, Nakhon Ratchasima Province, to be used. Try it out for the first time.

Dr. Yongyot further said that The digital platform system "Phoopphan" was created in which all types of users must enter their personal details. and confirm your identity in the system registration process To ensure safety of patient information Users are divided into 3 categories: 1. Citizens who can access information on their own pharmacogenetic test results. 2. Doctors and pharmacists Can access test result information by searching for information by ID card number or first and last name. And a data access request must be sent to the owner of the public before they can view the data. 3. Laboratory staff are the ones who report laboratory test results into the breeding system.

Dr. Piya Sirilak, Deputy Director-General of the Department of Medical Sciences Adding that "Tiepphan" is a system that supports Displaying test results on personal electronic health record applications such as Doctor Prom Health Link and Health for You can help people access their pharmacogenetic test results. It also helps reduce costs from redundant tests and reduces treatment costs if severe drug allergies occur. In addition, "Phoopphan" can link data with the hospital's information system or HIS Hospital Information System, making it Test results can be sent to the hospital system. However, the patient's consent must be obtained first. The Department of Medical Sciences hopes that "Tipphan" will be a good starting point for medicine and help doctors use the information to plan disease prevention and treatment more specifically and accurately. For hospitals interested in using You can contact us for details at Genomics Medical Center Institute of Medical Biosciences Department of Medical Sciences Tel. 02 951 0000 ext. 98096 or website http://phukphan.dmsc.moph.go.th.

Source: Thai News Agency